Physician profile
Ananth Mothukuri
NPI 1194958900
$832.27
in general payments reported to CMS, 2019-2025
10 companies · $174 in 2025
The $174 reported for 2025 was more than what 78% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $458 · 2023: $86.19 · 2024: $115 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $141.76 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Genentech USA, INC. | $135.00 | 2019 | |
| Seagen INC. | $112.70 | 2019 | |
| Fisher & Paykel Healthcare INC | $112.05 | 2024-2025 | Fisher & Paykel Healthcare |
| Exelixis INC. | $110.00 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $100.01 | 2019 | |
| Edwards Lifesciences Corporation | $51.25 | 2023 | Hemosphere |
| Cumberland Pharmaceuticals, INC. | $28.85 | 2023-2025 | Caldolor |
| Ge Healthcare | $21.61 | 2023 | |
| Medtronic, INC. | $19.04 | 2024 | Mcgrath Mac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ananth Mothukuri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.